BioNexus Gene Lab Corp. (BGLC) Stock

BioNexus Gene Lab Corp. (BGLC) is a Healthcare stock trading at $2.59 (as of 2026-06-18), with a market capitalization of $4.17M and a trailing P/E of -23.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

BioNexus Gene Lab Corp. operates through subsidiaries that (1) wholesale chemical raw material products in Malaysia, Indonesia, Vietnam, and other Southeast Asian countries, and (2) develop and provide non-invasive liquid biopsy tests for early detection of biomarkers. Chemrex Corporation Sdn. Bhd. supports the chemicals business, while BioNexus Gene Lab Sdn. Bhd. supports the diagnostic tests.

Valuation — source: SEC EDGAR (first-party)
Price$2.59
Market Cap$4.17M
P/E Ratio-23.8
EV / EBITDA-1.4
Price / Book0.64
Price / Sales0.97
DCF Value (model)$-12.22
DCF Upside vs Price-571.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$7.42M
Net Margin-40.2%
Return on Equity-35.9%
Current Ratio6.52
Revenue Growth (YoY)-21.9%
FCF Growth (YoY)-23.8%
Financial Health — source: SEC EDGAR
Altman Z-Score5.30 (safe)
Valuation vs Sector & Industry
Stock P/E-23.8
Sector P/E (Healthcare)21.0
Industry P/E (Healthcare Services)23.0
vs Sector-213.4%
vs Industry-203.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderCITADEL ADVISORS LLC ($23349.00)
Institutional Holders Tracked5
Company
SectorHealthcare
IndustryHealthcare Services
CEOSu-Leng Tan
Employees30
CountryMY
IPO Date2021-01-08

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Q/C Technologies, Inc. (QCLS)
  • Advanced Biomed Inc. Common Stock (ADVB)
  • American Shared Hospital Services (AMS)
  • Biomerica, Inc. (BMRA)
  • bioAffinity Technologies, Inc. (BIAF)
  • Cardio Diagnostics Holdings, Inc. (CDIO)
  • Aclarion, Inc. (ACON)
  • iSpecimen Inc. (ISPC)
BGLC earnings history · BGLC institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.